NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Related Questions
What is the expected timeline for the lawsuit resolution and how could it affect the stock's short‑term price movement?
Are there any indications of settlement negotiations, regulatory enforcement, or insider activity that could present arbitrage or hedging opportunities?
How might the alleged securities law violations impact Unicycive Therapeutics' valuation, earnings guidance, and potential financing needs?